Today, ACI joined 70 other organizations in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi. The bill would impose excise taxes up to 95% on hundreds of prescription medicines. You can read the coalition letter online. 10-15-19 Coalition Letter Opposed to Pelosi Drug Tax Plan
Health
Hill’s Congress Blog: The FDA Should Release Its Data on Youth Use of Tobacco
The FDA needs to release its data on teen vaping. Providing a comprehensive compilation of the facts to the public will provide transparency and assure that FDA regulators’ and the administration’s policies on vaping are well-informed and impactful for the whole country. American consumers deserve to know the facts. Read this op-ed in the Hill’s […]
ACI Joins a Coalition Calling on the FDA to Release Its Data on Teen Vaping
Today, ACI joins a 14 nonprofit organizations representing both consumers and taxpayers in sending a letter to the Acting Commissioner, Norman Sharpless. This letter calls for the FDA to release its data from the 2019 National Youth Tobacco Survey before moving any further with the proposed ban on vaping products. The public deserves to know […]
Coalition Letter to White House: Allow Adult Vapers Access to Flavored Products
Today, ACI joined a group of think tanks, consumer and tax groups urging the President to protect adult vapers by keeping flavored products legally available. The letter is available online.
Capital Hill Event: Drug Pricing Policy Prescriptions for 2020
On September 25, 2019, the American Consumer Institute held a policy briefing called “Pricing Policy Prescriptions for 2020: The Good, The Bad, and The Ugly.” The event included guest speaker John Fund, along with the following policy experts: Krisztina Pusok, Director of Policy and Research at the American Consumer Institute (moderating); Robert Graboyes is a Senior […]
Targeting E-cigarette Flavors is Blaming the Wrong Suspect
Over the last half-decade, vaping has helped reduce tobacco harm more than any other intervention. The FDA’s sweeping, knee-jerk policy change ignores the evidence and threatens to put lives at risk. Reducing the availability of flavored e-cigarettes will impose high costs on smokers while doing little to reduce vaping among teens. You can read this […]
Drug Pricing Policy Prescriptions for 2020: The Good, The Bad, and The Ugly — September 25, 2019
Senate Russell Office Building Featured Keynote Speaker: John Fund Topic: Escalating drug prices are generating a fierce political and policy debate. Join the American Consumer Institute on September 25th for a distinguished panel of experts who will discuss recent proposals put forth in Congress and the White House to address increasing prescription drug costs. Hear […]
Coalition Calls for Increased Generic Drug Competition
While the Lower Health Care Costs Act is intended to increase competition and patient access to lower cost medicines, section 205 of the bill needs to address FDA concerns about the “parking” of generic applications. We believe generic manufacturers need to launch new medications into the market as soon as possible after approval. However, as […]
Real Clear Health: Is American Alone in Its Vaping Hysteria?
If the U.S. wants to save lives, it should take notes from how other countries regulate e-cigarettes. Read this piece from Real Clear Health to learn why.
Townhall: Stop Using Kids as Political Props
With the rise of vaping has also come the fear of vaping. Yet despite all the progress of decade-low smoking rates among adults, teens and children have been used as the “Trojan Horse” to feed a non-evidence based hysteria. You can read why at Townhall.